HRMY
HRMY
US4131971040
Harmony Biosciences Holdings, I
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 868.453.000 714.734.000
21.5%
Cost of Revenue 198.342.000 156.815.000
26.5%
Gross Profit 670.111.000 557.919.000
20.1%
461.642.000 367.093.000
25.8%
Operating Income 208.469.000 190.826.000
9.2%
Pretax Income 215.064.000 191.804.000
12.1%
Net Income Common Stockholders 158.687.000 145.493.000
9.1%
-- --
--
-- --
--
ende